Allworth Financial’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.8K | Buy |
163
+120
| +279% | +$1.32K | ﹤0.01% | 3745 |
|
2025
Q1 | $411 | Sell |
43
-91
| -68% | -$870 | ﹤0.01% | 3725 |
|
2024
Q4 | $1.26K | Buy |
+134
| New | +$1.26K | ﹤0.01% | 3324 |
|
2024
Q1 | – | Sell |
-178
| Closed | -$2K | – | 3683 |
|
2023
Q4 | $2K | Buy |
178
+165
| +1,269% | +$1.86K | ﹤0.01% | 2681 |
|
2023
Q3 | $113 | Sell |
13
-93
| -88% | -$808 | ﹤0.01% | 3336 |
|
2023
Q2 | $1.1K | Hold |
106
| – | – | ﹤0.01% | 2700 |
|
2023
Q1 | $1.15K | Buy |
+106
| New | +$1.15K | ﹤0.01% | 2621 |
|
2022
Q2 | – | Sell |
-1,130
| Closed | -$11K | – | 2803 |
|
2022
Q1 | $11K | Hold |
1,130
| – | – | ﹤0.01% | 1469 |
|
2021
Q4 | $12K | Buy |
+1,130
| New | +$12K | ﹤0.01% | 1337 |
|